Canine Nervous System Tumors—Honorary Special Issue Commemorating the Work of Veterinary Neuropathologist Prof. Robert J. Higgins

A special issue of Veterinary Sciences (ISSN 2306-7381). This special issue belongs to the section "Veterinary Biomedical Sciences".

Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 33733

Special Issue Editors


E-Mail Website
Guest Editor
Laboratoire d’Histopathologie, VetAgro Sup, Campus Vétérinaire, 69280 Marcy l'etoile, France
Interests: canine meningioma; oncology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Laboratorio di Neuropatologia, Dip. di Medicina Veterinaria, Università degli Studi di Perugia, 06126 Perugia, Italy
Interests: nervous system; neuropathology; neuro-oncology; meningioma; enteric nervous system; domestic animals; dog
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Facultat de Veterinària, Campus UAB, Dept Medicina i cirurgia, Animals, 08193 Bellaterra (Cerdanyola del Vallès), Barcelona, Spain
Interests: neuropathology; neuro-oncology; glioma; neurodegeneration; prions; comparative pathology; animal law; veterinary history

Special Issue Information

Dear Colleagues,

During last Christmas days Dr. Robert Higgins, one of the most eminent veterinary neuropathologists since the seventies of last century, passed away. He has been a passionate teacher inspiring several students and residents to specialize in veterinary neuropathology. Moreover, in addition to his hundreds of papers on veterinary neuropathology, his special interest in Neuro-oncology has produced two of the fundamental and most referred books on these fields.

As his attached disciples, we wanted to pay tribute to Dr. Higgins by devoting our special volume of “Canine nervous system tumors” to him as homage, recognition and gratitude to his figure and work.

Nervous system tumors are rather frequent in dogs, accounting for 2–4.5% of tumors diagnosed at necropsy. Central nervous system tumors are mainly represented by meningiomas and gliomas, resulting in dramatic clinical signs, including seizures and behavioral changes. Additionally, for the spinal and cranial peripheral nerve sheath of dogs, tumors represent the most common affection, often calling for invasive/mutilating surgical approaches. Despite the relatively high frequency of tumors in the nervous system of dogs, and the consistent novel results obtained in recent years, morphological diagnosis, biological behavior, classification and genetic assessment still remain insufficient to support advanced prognostic and therapeutic approaches able to consistently improve the life quality of canine patients. 

The aim of this Special Issue is to collect the most current and advanced knowledge researchers are producing on canine nervous system tumors, addressing pathologic mechanisms, morphological and genetic diagnosis, and prognostic and therapeutic novel managements. 
Original research articles and reviews are welcomed, especially focusing on (but not limited to):
- epidemiology;
- imaging;
- neuropathology: morphology; immunohistochemistry; prognostic markers; immuno-oncology; 
- genetic;
- prognosis and biological behavior;
- advanced therapy and treatment response.

Papers in the form of case reports are also accepted, especially ones that cover new forms and variants.

We look forward to receiving your contributions.

Dr. Sara Belluco
Prof. Dr. Maria Teresa Mandara
Prof. Dr. Martí Pumarola
Guest Editors

IN MEMORIAM

Robert J. Higgins
1941–2021

(The picture was taken in November, 2017)

Robert (Bob) J. Higgins was born on 21 September 1941 in Perth, Western Australia, and died on 27 December 2021 in Davis, California, after a courageous battle with Parkinson’s Disease.

Childhood
Bob was born in Perth, Western Australia. The family moved to Toowoomba Queensland where Bob’s father worked for Southern Cross Machinery, an Australian company that manufactured windmills and irrigation equipment. An iconic feature of the Australian outback landscape, the Southern Cross windmill guaranteed access to reliable and consistent sources of underground water. Bob told of formative times when, as an adolescent on school holidays, he worked on rural properties operated by his father’s company, where he was called “the boss’s kid” and was given the most challenging (i.e., “dirtiest”) jobs.

When Bob was just twelve, he went to The Southport School, (a Church of England boarding school) which he disliked vehemently, and recalled the bullying he received being young for his class and a small kid. However, he did participate in the sport that was offered, and excelled at cricket and rugby.

Bob had a younger brother Richard, and a younger sister Suzanne, for whom he maintained a great affection, and with whom he exchanged long letters all his life. Bob’s love of the ocean and fishing was passed on from his father, whom he idolized. Bob was devastated when his father died at just 46 years of age. This loss, combined with his boarding school experience away from his family, had a profound and lifelong effect upon him.

Veterinary science
After graduating from high school, Bob was offered entrance into medicine, engineering, and veterinary science, at the University of Queensland. A full scholarship to study veterinary science was offered by the Department of Primary Industries (DPI) in Queensland. This scholarship paid for his university fees and college accommodation. He accepted the scholarship, but sometimes said that he regretted not having chosen medicine instead. However, the scholarship meant that he was then “bonded” to work for the DPI for five years following graduation.

Early years as a veterinarian
After graduating with a BVSc degree in 1963, the DPI sent Bob to remote Queensland towns (including places as remote as Thargomindah) as the local vet. He was conflicted. On one hand, he learned to fly and was able to discover the outback, about which he was passionate. On the other hand, he was frustrated by the sort of work (e.g., bovine tuberculosis testing) that outback vets in remote areas were required to do in those times.

In 1967, during the outbreak of foot and mouth disease in the United Kingdom, Bob was one of two veterinarians sent to the UK by the DPI. Overseeing the destruction of numerous animals on numerous farms, many of which had operated and bred prize animals for hundreds of years, and the tragedy of the loss experienced by the farmers, had a devastating effect upon Bob.

Bob returned to Perth, but was not satisfied working in a small animal veterinary practice. He was persuaded by a colleague who had studied in the United States to travel there to complete a Master’s degree. The only university that replied to his inquiry was Auburn University College of Veterinary Medicine in Alabama.

Auburn University
Having no idea about Alabama, or even where it was, courageously or foolhardily, Bob accepted the offer to study at Auburn University. He completed his residency and Master’s degree in anatomic pathology, and it was there he met his lifelong and best friend, Marc Vandevelde.

These years are best summed up in Marc’s words:

“The Australian accent of this good-looking young man, with many ‘colorful’ words, was sometimes difficult to understand, but many of us were fascinated by Bob’s intense personality, and he was a much-liked member of the ‘ex-pat community’. Bob could be very ‘moody’ at times, but usually was outgoing with a very strong sense of humor. He could deliver quick sardonic comments on almost any subject, often regardless of the consequences. He loved an argument, but emotions could quickly spill over. The weak-hearted sometimes found it difficult to get along with Bob, but very few did not eventually succumb to his charm. Perhaps because of his Australian heritage, Bob was what you might call a ‘macho man’ (although deep down prone to sentimentality), and he acted accordingly, but always with a wink, saying things like: ‘when men were still men, and women were thankful for it!’ Bob had a razor-sharp mind, and always was very quick to grasp even the most complex matters. He developed a special interest in the pathology of neurological diseases, and became a well-versed neuropathologist.”

The Ohio State University
In 1973, Bob graduated with a Master’s degree from Auburn University in Alabama, and moved to The Ohio State University (OSU) in Columbus, Ohio, to complete a PhD degree in the Department of Pathology.

At OSU, Bob completed research on the pathogenesis of canine distemper encephalitis, using the electron microscope, which was in those days an important technique in pathology. He made several interesting observations, the most important of which was the first evidence of viral-induced segmental demyelination in the central nervous system.

In 1980, Bob graduated with a PhD degree from OSU. During his years in Ohio, Bob married Sharon Stevenson, a veterinarian who had completed a residency in orthopedic surgery at OSU.

Bob then spent a year with Marc Vandevelde at the Institute of Comparative Neurology, University of Bern, Switzerland, continuing to work on canine distemper, skiing in the mountains (one of his favored activities), and taking French cooking lessons. This was followed by a year in Boston while Sharon completed an orthopedic fellowship.

University of California, Davis
In 1982, Bob joined the Department of Pathology, Microbiology & Immunology, School of Veterinary Medicine, at UC Davis in California.

Bob’s time at UC Davis is summed up in the words of Marc Vandevelde:

“Bob accepted a faculty position at the veterinary school in Davis, California, where he met (as he always said) ‘the love of his life’, Carolyn, and where his daughter Sophie was born. He worked for many years at UCD, focusing on neuropathology, and establishing an excellent relationship with the clinical neurology department. He trained residents and graduate students, generally being quite tough on them, but all of them really loved him.”

Bob and Carolyn met in San Francisco while attending a personal development conference designed to help attendees identify and resolve inherited patterns of behavior causing emotional and spiritual pain. Bob’s early experiences in Australia had shaped many of his views, and he constantly worked to understand and overcome the prejudices and behaviors to which he was exposed early in his life.

Bob and Carolyn’s daughter Sophie was born in 1991. Sophie is a physician specializing in cardiothoracic medicine and intensive care medicine. Bob was incredibly proud of his daughter, now 30 years of age, and Bob’s face would light up whenever he spoke of her. Sophie spent a year in Adelaide with Carolyn in 2005-06, and Bob was able to join them for six months of that time. Bob always spoke of this time with a huge smile on his face. Bob’s creative use of ‘colorful’ Aussie slang words lives on in Sophie.

Bob loved to travel, and was able to spend time with Carolyn in recent years traveling to Arnhem Land, Tasmania, Antarctica, and the Galapagos Islands, and in 2019 spent six weeks in his beloved Australia.

The above description of Bob’s achievements falls far short of the true impact he had on the field of veterinary neuropathology, the individuals he mentored and with whom he interacted, and his professional friendships. Bob impacted the lives of all he encountered. He served as a mentor to many residents in anatomic pathology and neurology, helping them survive some of their worst nightmare days by hearing their gossiping and drama, and having a good laugh together. He treated them with gratitude and admiration. He was upfront and forward about his interpretations.

He wrote (with coauthors Marc Vandevelde and Anna Overmann) a landmark textbook on neuropathology. Bob was a very active individual, with a love and enthusiasm for the outdoors and sports. Bob loved bees and orchids. He loved going fishing in Baja in his treasured van, and being captain for a day or two while sailing in San Francisco Bay under the Golden Gate Bridge.

In the words of Marc Vandevelde:

“Bob could get extremely excited about any aspect of neuropathology and often pursued a research idea with great enthusiasm - but he could just as quickly lose interest. Despite this somewhat ‘mercurial’ approach to science, Bob has greatly contributed to the field of diagnostic neuropathology as numerous publications testify on a wide range of subjects from infectious diseases to neurodegenerations. He became the expert on the classification and diagnosis of canine brain tumors, and published many well-cited papers on this subject. His interest in brain tumors fostered his last big research undertaking in the domain of comparative neuro-oncology, in collaboration with veterinary and human neurologists, promoting canine brain tumors as a model for human CNS neoplasms.”

“In addition to his devotion to family, Bob always had many other interests. Bob loved nature, and was all his life angry and sad about its progressive degradation. Born on the seashore, he was very much attached to the ocean. Bob was amazingly well read. He devoured mountains of books, from novels to political essays, and one of his first remarks upon meeting was often: ‘you should read this or that book’. He was not only interested in literature, but also in art and history. He traveled to many places in Europe visiting cities and museums, of which he never could get enough. He also loved to fly his little plane, and to play squash with great energy, although ultimately ruining his knees.”

Bob was humble in many ways and always shared his great embarrassment at knowing “so little”. He was committed to improving veterinary diagnostic neuropathology by collaborating with human neuropathologists, and he was an advocate for using spontaneous animal cancers, such as canine glioma, as translational models of human cancers. Unquestionably, his life was driven by his enthusiasm for learning and knowing more and more. He would shake his head and whisper “unbelievable”, while learning about the latest biotechnological advances in treating some neurodegenerative diseases, including Parkinson’s Disease.

Bob was a perfectionist when it came to the illustration of morphology. His love for art and morphology at its finest made him an avid admirer of Gustav Klimt’s exquisite artwork and a follower of Greg Dunn’s neuro art, including ink paintings on gold leaf fusing art and science. He was similarly critical when it came to the capture of images for veterinary articles or book figures. A great tribute to his demand for finesse and quality is embedded in each image panel in the chapter concerning tumors of the nervous system in the 5th edition of Tumors of Domestic Animals (2017). As Bob would say: “they are a beauty, and they will blow your mind”.

Perhaps ironically for a neuropathologist, Bob had the misfortune to develop Parkinson’s Disease. We witnessed the first signs, and then the slow progression of the degradation of his motor system until he was in a wheelchair and lost his ability to speak. This was a heart wrenching experience for all of us. Bob remained stoic until, perhaps mercifully, pneumonia took him away suddenly. We will always remember Bob as a remarkable person, a fine neuropathologist, and a great friend.

Bob is greatly missed by all who interacted with him, knew him, and loved him. We are saddened by his death, and stand beside his family in remembering the wonderful individual that he was. Bob always said that his greatest legacy is his family. Vale Bob.

Life and Times.

Rick LeCouteur
Marc Vandevelde
Sílvia Sisó

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Veterinary Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • dog
  • nervous system tumor
  • comparative oncology
  • omics
  • molecular biology
  • pathology
  • imaging
  • clinic
  • therapy

Published Papers (10 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

15 pages, 5538 KiB  
Article
Nerve Fiber Immunohistochemical Panel Discriminates between Nerve Sheath and Perivascular Wall Tumors
by Sílvia Sisó, Paola Marco-Salazar, Paola Roccabianca, Giancarlo Avallone, Robert J. Higgins and Verena K. Affolter
Vet. Sci. 2023, 10(1), 1; https://doi.org/10.3390/vetsci10010001 - 21 Dec 2022
Cited by 2 | Viewed by 2067
Abstract
Benign and malignant nerve sheath tumors (NST) pose a major challenge in routine diagnostic anatomic pathology because of shared histomorphological features with other soft-tissue tumors (STT). As a result, NST are often diagnosed as STT, a broad category that encompasses various entities including [...] Read more.
Benign and malignant nerve sheath tumors (NST) pose a major challenge in routine diagnostic anatomic pathology because of shared histomorphological features with other soft-tissue tumors (STT). As a result, NST are often diagnosed as STT, a broad category that encompasses various entities including perivascular wall tumors (PWT) and that represents approximately 15% of all skin tumors in dogs. Immunohistochemistry (IHC) can assist the identification of histologic subtypes of STT. This IHC pilot study applies various markers largely expressed by peripheral nerves to twelve benign and six malignant NST and determines the intratumoral protein expression of laminin, periaxin-1, Sox-10 and S-100 in the NST subtypes. Furthermore, this study assesses the usefulness of peripheral nerve markers applied to diagnostic work cases and demonstrates the relevance of laminin expression patterns, periaxin-1 and Sox-10 in assisting the differentiation of NST from other STT, in particular from PWT. Full article
Show Figures

Figure 1

14 pages, 1434 KiB  
Article
Survival Time after Surgical Debulking and Temozolomide Adjuvant Chemotherapy in Canine Intracranial Gliomas
by Emma Hidalgo Crespo, Alba Farré Mariné, Martí Pumarola i Battle, Juan Francisco Borrego Massó and Alejandro Luján Feliu-Pascual
Vet. Sci. 2022, 9(8), 427; https://doi.org/10.3390/vetsci9080427 - 12 Aug 2022
Cited by 7 | Viewed by 3155
Abstract
Intracranial gliomas are associated with a poor prognosis, and the most appropriate treatment is yet to be defined. The objectives of this retrospective study are to report the time to progression and survival times of a group of dogs with histologically confirmed intracranial [...] Read more.
Intracranial gliomas are associated with a poor prognosis, and the most appropriate treatment is yet to be defined. The objectives of this retrospective study are to report the time to progression and survival times of a group of dogs with histologically confirmed intracranial gliomas treated with surgical debulking and adjuvant temozolomide chemotherapy. All cases treated in a single referral veterinary hospital from 2014 to 2021 were reviewed. Inclusion criteria comprised a histopathological diagnosis of intracranial glioma, adjunctive chemotherapy, and follow-up until death. Cases were excluded if the owner declined chemotherapy or there was insufficient follow-up information in the clinical records. Fourteen client-owned dogs were included with a median time to progression (MTP) of 156 days (95% CI 133–320 days) and median survival time (MST) of 240 days (95% CI 149–465 days). Temozolomide was the first-line adjuvant chemotherapy but changed to another chemotherapy agent (lomustine, toceranib phosphate, or melphalan) when tumour relapse was either suspected by clinical signs or confirmed by advanced imaging. Of the fourteen dogs, three underwent two surgical resections and one, three surgeries. Survival times (ST) were 241, 428, and 468 days for three dogs treated twice surgically and 780 days for the dog treated surgically three times. Survival times for dogs operated once was 181 days. One case was euthanized after developing aspiration pneumonia, and all other cases after progression of clinical signs due to suspected or confirmed tumour relapse. In conclusion, the results of this study suggest that debulking surgery and adjuvant chemotherapy are well-tolerated options in dogs with intracranial gliomas in which surgery is a possibility and should be considered a potential treatment option. Repeated surgery may be considered for selected cases. Full article
Show Figures

Figure 1

18 pages, 1861 KiB  
Article
Clinical and Magnetic Resonance Imaging (MRI) Features, Tumour Localisation, and Survival of Dogs with Presumptive Brain Gliomas
by Marta Pons-Sorolla, Elisabet Dominguez, Michał Czopowicz, Anna Suñol, Christian Maeso Ordás, Carles Morales Moliner, Marc Pérez Soteras and Patrícia Montoliu
Vet. Sci. 2022, 9(6), 257; https://doi.org/10.3390/vetsci9060257 - 27 May 2022
Cited by 2 | Viewed by 4124
Abstract
Brain gliomas are common tumours diagnosed in dogs. However, limited information is available on the clinical features and overall survival time (OS) in dogs receiving palliative treatment. The aim of this study was to evaluate possible associations between presenting complaint, tumour localisation, Magnetic [...] Read more.
Brain gliomas are common tumours diagnosed in dogs. However, limited information is available on the clinical features and overall survival time (OS) in dogs receiving palliative treatment. The aim of this study was to evaluate possible associations between presenting complaint, tumour localisation, Magnetic Resonance Imaging (MRI) features, survival times, and reason for the death of dogs with suspected intracranial glioma treated palliatively. Sixty dogs from a single institution were retrospectively included (from September 2017 to December 2021). Dogs were included if a presumptive diagnosis of brain glioma was obtained based on an MRI scan and medical history. French Bulldogs were overrepresented (40/60); 46 out of 60 dogs (77%) presented due to epileptic seizures (ES) and in 25/60 dogs (42%), cluster seizures or status epilepticus were the first manifestation of the disease. Dogs with suspected gliomas located in the piriform lobe showed a higher probability of presenting due to epilepsy compared to dogs with glioma in other regions, and more frequently died or were euthanised because of increased ES. Magnetic Resonance Imaging (MRI) features differed between localisations. Fronto-olfactory tumours were more frequently, whereas piriform tumours were less frequently, classified as suspected high-grade glioma. The median survival time was 61 days. Dogs with contrast-enhancing suspected gliomas had significantly shorter OS. This study provides additional information on the clinical features and survival of dogs with suspected brain gliomas treated palliatively. Full article
Show Figures

Figure 1

27 pages, 7125 KiB  
Article
Histopathological and Immunohistochemical Evaluation of Canine Nerve Sheath Tumors and Proposal for an Updated Classification
by Kristina Tekavec, Tanja Švara, Tanja Knific, Mitja Gombač and Carlo Cantile
Vet. Sci. 2022, 9(5), 204; https://doi.org/10.3390/vetsci9050204 - 22 Apr 2022
Cited by 8 | Viewed by 4737
Abstract
Nerve sheath tumors are a group of tumors originating from Schwann cells, fibroblasts, and perineurial cells. In veterinary pathology, the terminology for nerve sheath tumors remains inconsistent, and many pathologists follow the human classification of such tumors in practice. Immunohistochemistry plays an important [...] Read more.
Nerve sheath tumors are a group of tumors originating from Schwann cells, fibroblasts, and perineurial cells. In veterinary pathology, the terminology for nerve sheath tumors remains inconsistent, and many pathologists follow the human classification of such tumors in practice. Immunohistochemistry plays an important role in the diagnosis of nerve sheath tumors, but specific immunohistochemical and molecular biomarkers are lacking. In our study, we histopathologically reevaluated 79 canine nerve sheath tumors and assessed their reactivity for the immunohistochemical markers Sox10, claudin-1, GFAP, CNPase, and Ki-67. Based on the results, we classified the tumors according to the most recent human classification. Twelve cases were diagnosed as benign nerve sheath tumors, including six neurofibromas, three nerve sheath myxomas, two hybrid nerve sheath tumors (perineurioma/neurofibroma and perineurioma/schwannoma), and one schwannoma. Sixty-seven tumors were malignant nerve sheath tumors, including fifty-six conventional, four perineural, one epithelioid malignant nerve sheath tumor, and six malignant nerve sheath tumors with divergent differentiation. We believe that with the application of the proposed panel, an updated classification of canine nerve sheath tumors could largely follow the recent human WHO classification of tumors of the cranial and paraspinal nerves, but prospective studies would be needed to assess its prognostic value. Full article
Show Figures

Figure 1

9 pages, 817 KiB  
Article
European Mistletoe (Viscum album) Extract Is Cytotoxic to Canine High-Grade Astrocytoma Cells In Vitro and Has Additive Effects with Mebendazole
by Anna Wright, Rie Watanabe and Jey W. Koehler
Vet. Sci. 2022, 9(1), 31; https://doi.org/10.3390/vetsci9010031 - 15 Jan 2022
Cited by 4 | Viewed by 4171
Abstract
Malignant gliomas are associated with extremely poor clinical outcomes in both humans and dogs, and novel therapies are needed. Glioma-bearing canine patients may serve as promising preclinical models for human therapies, including complementary medicine. The objective of this study was to evaluate the [...] Read more.
Malignant gliomas are associated with extremely poor clinical outcomes in both humans and dogs, and novel therapies are needed. Glioma-bearing canine patients may serve as promising preclinical models for human therapies, including complementary medicine. The objective of this study was to evaluate the effects of mistletoe extract (Viscum album) alone and in combination with mebendazole in an in vitro model of canine high-grade astrocytoma using the cell line SDT-3G. SDT-3G cells were exposed to a range of concentrations of mistletoe extract alone to obtain an IC50. In separate experiments, cells were exposed to mebendazole at a previously determined IC50 (0.03 µM) alone or in conjunction with varying concentrations of mistletoe extract to determine the additive effects. The IC50 for mistletoe alone was 5.644 ± 0.09 SD μg/mL. The addition of mistletoe at 5 μg/mL to mebendazole at 0.03 µM led to increased cell death compared to what would be expected for each drug separately. The cytotoxicity of mistletoe in vitro and its additive effect with mebendazole support future expanded in vitro and in vivo studies in dogs and supply early evidence that this may be a useful adjunct therapeutic agent for use in glioma-bearing dogs. To the authors’ knowledge, this is the first published report of Viscum album extract in canine glioma. Full article
Show Figures

Figure 1

Other

Jump to: Research

11 pages, 2244 KiB  
Case Report
Metastatic Multifocal Malignant Peripheral Nerve Sheath Tumour in the Cervicothoracic Spinal Cord of a Dog Initially Mimicking Meningomyelitis
by Javier Espinosa, María Ortega, Martí Pumarola, Eduardo Fraga and Laura Martín
Vet. Sci. 2023, 10(2), 170; https://doi.org/10.3390/vetsci10020170 - 20 Feb 2023
Viewed by 3514
Abstract
A nine year old cross-breed dog was presented with a two week history of ambulatory tetraparesis and proprioceptive ataxia affecting all four limbs. Meningomyelitis of Unknown Origin (MUO) was presumptively diagnosed based on the magnetic resonance imaging (MRI) findings and cerebrospinal fluid (CSF) [...] Read more.
A nine year old cross-breed dog was presented with a two week history of ambulatory tetraparesis and proprioceptive ataxia affecting all four limbs. Meningomyelitis of Unknown Origin (MUO) was presumptively diagnosed based on the magnetic resonance imaging (MRI) findings and cerebrospinal fluid (CSF) analysis. The dog received a tapering dose of glucocorticoids and cyclosporine, showing significant improvement and the stabilization of the clinical signs for seven months. After this period, the dog showed an acute clinical deterioration and a follow-up MRI revealed new multiple lesions affecting different spinal nerve roots along the cervicothoracic spinal cord. Following euthanasia, a final diagnose of multiple malignant peripheral nerve sheath tumors (MPNSTs) was made based on the histopathological examination. MPNSTs can affect the cranial nerves, spinal nerves or the associated nerve roots at any location and can lead to secondary spinal cord compression. The aim of the present case report is to describe the clinical presentation and atypical MRI findings of a dog with histologically confirmed multiple MPNSTs. According to the reviewed literature, this is the first reported case of simultaneous MPNSTs in the cervicothoracic spinal cord of a dog. Full article
Show Figures

Figure 1

11 pages, 3796 KiB  
Case Report
Intracranial Granular Cell Tumours in Three Dogs: Atypical Magnetic Resonance Imaging Features and Immunohistochemical Study
by Clàudia Mayor, Judit Verdés, Jaume Alomar, Rosa Novellas, Martí Pumarola and Sònia Añor
Vet. Sci. 2023, 10(2), 134; https://doi.org/10.3390/vetsci10020134 - 09 Feb 2023
Cited by 1 | Viewed by 2205
Abstract
Intracranial granular cell tumours (GCT) are uncommon neoplasms of uncertain cellular origin that are rarely reported in dogs. This case series describes three aged dogs that presented with neurological signs in which magnetic resonance (MR) imaging revealed plaquelike extra-axial lesions that were hypointense [...] Read more.
Intracranial granular cell tumours (GCT) are uncommon neoplasms of uncertain cellular origin that are rarely reported in dogs. This case series describes three aged dogs that presented with neurological signs in which magnetic resonance (MR) imaging revealed plaquelike extra-axial lesions that were hypointense on T2-weighted (T2w) images. The surgical biopsy of the lesions and necropsies were followed by histochemical characterisation with periodic acid–Schiff (PAS) staining and immunohistochemistry with ubiquitin, S-100, and SOX-10 to elucidate the cellular origin. The immunohistochemical study indicated that these intracranial GCTs were not of Schwann cell origin. In conclusion, GCTs should be considered a differential diagnosis of intracranial, extra-axial hypointense brain lesions on T2w MR images. Full article
Show Figures

Figure 1

13 pages, 6268 KiB  
Case Report
Intracranial Subdural Fluid Accumulation Associated with a Choroid Plexus Carcinoma in a Dog
by Nina Schneider, Andreas Blutke, Kaspar Matiasek and Birgit Parzefall
Vet. Sci. 2023, 10(1), 24; https://doi.org/10.3390/vetsci10010024 - 30 Dec 2022
Cited by 2 | Viewed by 3085
Abstract
Choroid plexus tumors are commonly described as intraventricular mass lesions and account for 7–10% of intracranial, primary tumors in dogs. A 3-year-old Shetland sheepdog was presented with a history of slowly progressive lethargy, vision impairment and cognitive deficits. On magnetic resonance imaging, a [...] Read more.
Choroid plexus tumors are commonly described as intraventricular mass lesions and account for 7–10% of intracranial, primary tumors in dogs. A 3-year-old Shetland sheepdog was presented with a history of slowly progressive lethargy, vision impairment and cognitive deficits. On magnetic resonance imaging, a subdural fluid accumulation (SFA) overlying and compressing the left parietotemporal lobe as well as multifocal changes consisting of cyst-like lesions, supposed intra-axial brain lesions and mild, multifocal meningeal thickening and generalized contrast enhancement were identified. Cerebrospinal fluid (CSF) analysis showed a mononuclear pleocytosis with negative results for infectious agents. The dog was treated with prednisolone followed by burr hole craniotomy with puncture of the SFA, which macroscopically appeared to be CSF-like fluid. After initial improvement, the dog deteriorated despite continuation of prednisolone and cytarabine therapy and was euthanized four weeks after surgery. Histopathology was consistent with a disseminated, neuroinvasive choroid plexus carcinoma (CPC) that involved the entire neuroaxis including the meninges of the brain and spinal cord. Immunohistochemical examination showed a strong Kir7.1 and a heterogenous cytokeratin-immunoreactivity in neoplastic cells. In conclusion, a CPC should be considered as a possible cause of a SFA even in the absence of an intraventricular mass lesion. Full article
Show Figures

Figure 1

9 pages, 9364 KiB  
Case Report
A High Grade Astrocytoma with Pilocytic Morphology in a 5-Month-Old American Bulldog
by Kelly Muller, Eunbee Kim, Abbie Lebowitz and Heather Daverio
Vet. Sci. 2022, 9(10), 580; https://doi.org/10.3390/vetsci9100580 - 20 Oct 2022
Cited by 1 | Viewed by 2019
Abstract
A 23-week-old female intact American Bulldog was presented for a two-week history of progressive circling to the right, twitching, and altered mentation. Magnetic resonance imaging (MRI) revealed a non-contrast enhancing hemorrhagic mass centered in the right thalamus with concurrent subdural and intraventricular hemorrhage. [...] Read more.
A 23-week-old female intact American Bulldog was presented for a two-week history of progressive circling to the right, twitching, and altered mentation. Magnetic resonance imaging (MRI) revealed a non-contrast enhancing hemorrhagic mass centered in the right thalamus with concurrent subdural and intraventricular hemorrhage. Post-mortem histologic examination of the brain confirmed a mass centered on the thalamus with histomorphologic features consistent with a high-grade astrocytoma with pilocytic morphology. To the authors’ knowledge, the present case is the first to report clinical and imaging characteristics of a high-grade astrocytoma with pilocytic morphology in a young dog. Full article
Show Figures

Figure 1

8 pages, 18152 KiB  
Case Report
First Case of a Cerebrocortical Ganglioglioma in a Dog
by Laura Martín, Martí Pumarola, Raúl Altuzarra, Javier Espinosa and María Ortega
Vet. Sci. 2022, 9(10), 514; https://doi.org/10.3390/vetsci9100514 - 21 Sep 2022
Viewed by 2033
Abstract
Gangliogliomas are extremely rare tumors of the nervous system composed of neoplastic glial and neuronal cells. The aim of the present paper is to describe the clinical presentation, magnetic resonance imaging (MRI) findings and histopathological and immunophenotypical characteristics of a cerebral cortex ganglioglioma [...] Read more.
Gangliogliomas are extremely rare tumors of the nervous system composed of neoplastic glial and neuronal cells. The aim of the present paper is to describe the clinical presentation, magnetic resonance imaging (MRI) findings and histopathological and immunophenotypical characteristics of a cerebral cortex ganglioglioma in a 7-year-old Border Collie. The dog presented an acute onset of tonic-clonic epileptic seizures. MRI revealed a well-defined large intra-axial mass located on the left forebrain, mainly affecting the frontal cortex. Following humane euthanasia, the histopathological examination of the mass revealed a diffuse proliferation of neoplastic glial cells mixed with anomalous neuronal bodies. Immunohistochemical analyses confirmed the presence of two different populations of neoplastic cells. Most neoplastic glial cells were immunoreactive to glial fibrillary acidic protein (GFAP) and the other subset of neoplastic cells were positive to neuronal markers such as PGP 9.5, synaptophysin (SYN) and neuron-specific enolase (NSE), suggestive of neuronal cells. These findings confirmed the diagnosis of a cerebrocortical ganglioglioma. To the authors knowledge, this is the first description of a ganglioglioma of the cerebral cortex in a dog. Full article
Show Figures

Figure 1

Back to TopTop